Direct Meds GLP‑1 review
An independent look at Direct Meds GLP-1: what it charges, which medications it prescribes, how it verifies, and who it suits.
No FDA warning letter on file for Direct Meds GLP-1 in the warning letter register this site maintains from the FDA’s published list.
What you are buying
Direct-to-consumer GLP-1 access with competitive pricing. Direct Meds GLP-1 prescribes Compounded semaglutide, Compounded tirzepatide as sublingual, injection. Everything it dispenses is compounded: mixed by a pharmacy to a prescription rather than made by the manufacturer, and never through FDA approval as a product. It ships to 48 states — All US states except Mississippi and Louisiana, 'where state regulations currently restrict the prescribing of weight-management medications via telehealth'.
Direct Meds GLP-1 does not bill insurance. The prices below are what you pay. The medication is included in the monthly price. It says it dispenses through a 503A pharmacy, which it does not name.
What the medication actually costs
Context before the programme price: what a pharmacy pays to acquire the branded equivalent. Direct Meds GLP-1 sets its own price on top of a compounded or branded supply.
Source: CMS NADAC. This is what pharmacies pay, not a retail price and not what you would be charged.
Plans and what they cost
Every price is the lowest we can verify for that medication, normalised to one month so a prepay plan compares honestly against a monthly one.
Last read Aug 13, 2026 from the provider’s own site. The page we read
The catch: Compounded medications only — not FDA-approved brand drugs.
What three months really costs
A discounted first month makes a programme look cheaper than it is. This is that month plus two at the standing rate.
Medication only, at the lowest verified rate. Any membership or consultation fee is listed separately above and is not in this total.
What is included
How it checks out
| Check | What we found | Source |
|---|---|---|
| Partner pharmacy | 503A | Provider site |
| LegitScript | Certification badge displayed | Provider site |
| States served | 48 states — All US states except Mississippi and Louisiana, 'where state regulations currently restrict the prescribing of weight-management medications via telehealth'. | Provider site |
| Cancellation | Cancel anytime | Provider terms |
The safety record
We hold no FDA warning letter against Direct Meds GLP-1. That is an absence of enforcement, not a clearance — the checks above are what we can actually verify.
The honest scorecard
Strong Direct Meds GLP‑1 alternatives
Direct Meds GLP‑1 FAQ
In this section (1)
- CMS NADACNational Average Drug Acquisition Cost, weekly file
- CMS Medicare Part DPrescriber public use file, by geography and drug
- CMS State Drug UtilizationQuarterly Medicaid prescription and reimbursement data
NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.